Stryker Corporation (NYSE:SYK) – Analysts at William Blair upped their FY2017 EPS estimates for Stryker in a report issued on Tuesday. William Blair analyst K. Krum now forecasts that the medical technology company will post earnings per share of $6.50 for the year, up from their prior estimate of $6.46. William Blair also issued estimates for Stryker’s Q4 2017 earnings at $1.97 EPS, Q1 2018 earnings at $1.56 EPS, Q3 2018 earnings at $1.76 EPS and FY2018 earnings at $7.15 EPS.
Stryker (NYSE:SYK) last announced its quarterly earnings data on Thursday, October 26th. The medical technology company reported $1.52 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.50 by $0.02. The business had revenue of $3.01 billion for the quarter, compared to analyst estimates of $2.97 billion. Stryker had a net margin of 14.67% and a return on equity of 24.11%. The company’s revenue was up 6.1% on a year-over-year basis. During the same period in the prior year, the firm posted $1.39 EPS.
Stryker (SYK) opened at $159.54 on Wednesday. The firm has a market cap of $59,710.00, a PE ratio of 34.02, a PEG ratio of 2.30 and a beta of 0.78. Stryker has a 1-year low of $119.17 and a 1-year high of $164.20. The company has a current ratio of 2.37, a quick ratio of 1.61 and a debt-to-equity ratio of 0.63.
Several institutional investors and hedge funds have recently bought and sold shares of SYK. Jaffetilchin Investment Partners LLC grew its position in shares of Stryker by 41.5% during the fourth quarter. Jaffetilchin Investment Partners LLC now owns 2,215 shares of the medical technology company’s stock worth $343,000 after buying an additional 650 shares in the last quarter. Sit Investment Associates Inc. grew its position in shares of Stryker by 114.3% during the fourth quarter. Sit Investment Associates Inc. now owns 825 shares of the medical technology company’s stock worth $128,000 after buying an additional 440 shares in the last quarter. Founders Capital Management LLC grew its position in shares of Stryker by 1.4% during the fourth quarter. Founders Capital Management LLC now owns 25,790 shares of the medical technology company’s stock worth $3,993,000 after buying an additional 350 shares in the last quarter. DnB Asset Management AS grew its position in shares of Stryker by 2.8% during the fourth quarter. DnB Asset Management AS now owns 36,495 shares of the medical technology company’s stock worth $5,651,000 after buying an additional 1,000 shares in the last quarter. Finally, Oak Point Wealth Management acquired a new stake in shares of Stryker during the fourth quarter worth approximately $145,000. Institutional investors own 74.90% of the company’s stock.
In other news, insider Lonny J. Carpenter sold 5,000 shares of Stryker stock in a transaction that occurred on Friday, November 3rd. The shares were sold at an average price of $155.34, for a total transaction of $776,700.00. Following the sale, the insider now owns 83,207 shares in the company, valued at $12,925,375.38. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 7.40% of the company’s stock.
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 31st. Stockholders of record on Friday, December 29th will be paid a dividend of $0.47 per share. The ex-dividend date is Thursday, December 28th. This represents a $1.88 dividend on an annualized basis and a dividend yield of 1.18%. This is a positive change from Stryker’s previous quarterly dividend of $0.43. Stryker’s dividend payout ratio (DPR) is currently 40.09%.
Stryker Company Profile
Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.
Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.